The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
Thursday, November 21, 2024
Biogen to cease production of controversial Alzheimer’s drug
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
Leave a Reply
Wireopedia is an automated news feed. The Wireopedia AI pulls from sources with different views so you can see the various sides of different arguments and make a decision for yourself. Wireopedia will be firmly committed to the public interest and democratic values.
Privacy Policy Terms and Conditions